The goals of this clinical study are to learn more about the study drug, GS-0272, and its safety and tolerability following multiple doses in participants with rheumatoid arthritis (RA). The primary objectives of this study are to assess the safety and tolerability of multiple ascending doses of GS-0272 and to characterize the pharmacokinetics of GS-0272 following multiple doses of GS-0272, in participants with RA.
Rheumatoid Arthritis
The goals of this clinical study are to learn more about the study drug, GS-0272, and its safety and tolerability following multiple doses in participants with rheumatoid arthritis (RA). The primary objectives of this study are to assess the safety and tolerability of multiple ascending doses of GS-0272 and to characterize the pharmacokinetics of GS-0272 following multiple doses of GS-0272, in participants with RA.
Study of GS-0272 in Participants With Rheumatoid Arthritis
-
1238 E. Arrow Hwy, Upland, California, United States, 91786
Clinical Research of West Florida, Inc., Clearwater, Florida, United States, 33765
Jacksonville Center for Clinical Research, Jacksonville, Florida, United States, 32216
Altoona Center for Clinical Research, Duncansville, Pennsylvania, United States, 16635
1600 Republic Parkway, Mesquite, Texas, United States, 75150
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to 75 Years
ALL
No
Gilead Sciences,
Gilead Study Director, STUDY_DIRECTOR, Gilead Sciences
2025-06